MAPay strengthens delivery of Blockchain Healthcare payments and data internationally with new Chief Global Strategy Officer
New C-Suite support added to strengthen international operations and access to MAPay technology and services worldwide
VOORHEES, NJ, March 22, 2023 /PRNewswire/ — MAPay, the global healthcare fintech company revolutionizing healthcare payments and data exchange with distributed ledger and blockchain technology, announced the appointment of Robert Metz as the company’s new Chief Global Strategy Officer. Metz will assist the MAPay team with global origination and partnership opportunities, along with providing strategic advice for the implementation of MAPay solutions internationally.
Mr. Metz is a pioneer in the biotechnology and pharmaceutical industries, with more than 20 years of executive-level experience building successful national and international startups from the ground up to operational excellence. Reports directly to Michael Dershemfounder and CEO of MAPay, Metz will be responsible for sourcing and evaluating international deal flow, as well as advancing the global strategy to provide more countries and organizations with MAPay’s patented blockchain healthcare solutions that transform medical payments and data for entire countries.
“We believe the opportunity is ripe to improve healthcare delivery worldwide with MAPay’s first-ever blockchain-enabled vault wallet with two-way payments, data and secure messaging,” explained Dershem. “Adding Rob’s dynamism to our team will enhance our ability to connect the critical systematic health needs with secure, systematic blockchain technology to improve the efficiency of healthcare worldwide.”
Metz will work with three main groups, providers, payers and patients, to obtain contracts and data, collaborate and enable open source, permissioned distributed ledger solutions that have the potential to deliver significant global economic and social impact.
“My background with many biotech startups and significant depth of cross-functional industry experience make this challenging role with MAPay a perfect fit for me,” said Metz. “I am eager to empower patients and healthcare providers to leverage MAPay’s blockchain technology to improve and align incentives, significantly reduce systemic healthcare costs and increase transparency of data exchange. This is truly a once-in-a-lifetime opportunity to improve healthcare delivery.” and alleviate health inequities around the world.”
A native of Lake Forest, IL and Longboat Key, Florida, where Metz spent most of his personal and professional life Chicago area, previously worked as founder and CEO of Armor Life Sciences and was a key operational founder and senior vice president of Global Business Operations and External Affairs at Horizon Therapeutics. Robert Metz received his bachelor’s degree in management and economics from Marietta College and actively participates in a number of local healthcare and community-related 501c3 organizations.
About MAPay
MAPay is a global healthcare fintech company that implements distributed ledger technology to power smart contracts and execute secure medical solutions. The company has developed a hybrid architecture of both centralized and decentralized protocols for multi-party medical payments and HIPAA-compliant data exchange. MAPay works in collaboration with hospital networks, practice management systems, pharmaceutical companies, insurance payers, pharmacies and public entities. The company is committed to empowering patients and healthcare professionals by leveraging blockchain technology to improve and align incentives, reduce costs and provide increased transparency and data sharing. The company believes in permitted open source system collaboration, and solution sets that are economically and socially impactful. For more information, please visit
SOURCE MAPay
